NEW YORK (GenomeWeb News) – Johnson & Johnson Pharmaceutical Research and Development has extended a licensing agreement for BioWisdom’s OmniViz visualization and data-mining software, BioWisdom said today.

BioWisdom merged with OmniViz early last year.

The OmniViz software offers visualization of text, numerical, and categorical data as well as genome sequences, chemical structures, and text files.

Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.